Milpharm Limited Issues Class 4 Medicines Defect Notification for Loperamide Hydrochloride
A discrepancy has been identified in the Patient Information Leaflet for Loperamide hydrochloride 2 mg Orodispersible Tablets.
Therapeutic Area
Therapeutic area intelligence for Antidiarrheal with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.